Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Venous Thromboembolism 2Thrombosis 2Hemorrhage 2Venous Thrombosis 1Thromboembolism 1Thrombocytopenia 1Sarcoma 1Pulmonary Embolism 1Pancreatic Neoplasms 1Liver Neoplasms 1Hematoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Bone Neoplasms 1

Interventions

Tranexamic Acid 2Misoprostol 2Enoxaparin 2Dalteparin 2carbetocin 1Vitamin B 6 1Vasopressins 1Uterine Artery Embolization 1Tourniquets 1Tinzaparin 1Terlipressin 1Sodium Chloride 1Sensitivity Training Groups 1Rivaroxaban 1Oxytocin 1Ibuprofen 1Ethamsylate 1Bupivacaine 1Arginine Vasopressin 1Arginine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Hemorrhage × Enoxaparin × Clear all
NCT04731558 2025-02-14

PREPOSTEROUS

Helsinki University Central Hospital

Phase 4 Recruiting
1,012 enrolled
Gastrointestinal

Hemorrhage, Liver Neoplasms, Pulmonary Embolism, Venous Thrombosis

NCT05245877 2025-02-14

PREPOSTEROUS2

Helsinki University Central Hospital

Phase 4 Recruiting
800 enrolled
Gastrointestinal

Hemorrhage, Pancreatic Neoplasms, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡